High-dose clarithromycin is an active monotherapy for patients with relapsed/refractory extranodal marginal zone lymphoma of mucosa-associated lymphoid tissue (MALT): the HD-K phase II trial. [electronic resource]
Producer: 20160421Description: 1760-5 p. digitalISSN:- 1569-8041
- Aged
- Aged, 80 and over
- Anti-Bacterial Agents -- administration & dosage
- Breast Neoplasms -- drug therapy
- Clarithromycin -- administration & dosage
- Colorectal Neoplasms -- drug therapy
- Disease-Free Survival
- Eye Neoplasms -- drug therapy
- Female
- Humans
- Lymphoma, B-Cell, Marginal Zone -- drug therapy
- Male
- Middle Aged
- Mouth Neoplasms -- drug therapy
- Neoplasms, Multiple Primary -- drug therapy
- Salvage Therapy
- Skin Neoplasms -- drug therapy
- Stomach Neoplasms -- drug therapy
No physical items for this record
Publication Type: Clinical Trial, Phase II; Journal Article
There are no comments on this title.
Log in to your account to post a comment.